Brief: Infant Bacterial Therapeutics Jan-March Operating Loss Slightly Widens To SEK 9.1 Million
15/05/2018 07:07
May 15 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB
IBTb.ST :
* JAN-MARCH OPERATING LOSS SEK 9.1 MILLION VERSUS LOSS SEK
8.6
MILLION YEAR AGO
Source text for Eikon: ID:nGNE7b8rHx
Further company coverage: IBTb.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln